Header

Header

Acceleron

Latest News

October 10, 2022
155

Merck touts positive results on drug from $11.5 billion Acceleron merger
Latest News

December 2, 2018
150

Celgene Corporation and Acceleron Pharma Announce Results of the Phase 3 MEDALIST Trial Evaluating Luspatercept in Patients with Myelodysplastic Syndromes at the ASH 2018 Plenary Session
Latest News

December 1, 2018
144

Celgene Corporation and Acceleron Pharma Announce Results of the Phase 3 BELIEVE Trial Evaluating Luspatercept in Adult Patients with Beta-Thalassemia at ASH 2018
Latest News

December 1, 2018
138

STAT Plus: The benefit of a blood disease drug from Acceleron and Celgene debated by experts